[PDF][PDF] Advances in brain metastases diagnosis: non-coding RNAs as potential biomarkers
AM Eraky - Cureus, 2023 - cureus.com
Brain metastasis is considered the most common brain tumor. They arise from different
primary cancers. The most common primary tumors giving brain metastases include breast …
primary cancers. The most common primary tumors giving brain metastases include breast …
[HTML][HTML] MiRNAs as new potential biomarkers and therapeutic targets in brain metastasis
O Beylerli, H Shi, S Begliarzade, A Shumadalova… - Non-coding RNA …, 2024 - Elsevier
Brain metastases represent a formidable challenge in cancer management, impacting a
significant number of patients and contributing significantly to cancer-related mortality …
significant number of patients and contributing significantly to cancer-related mortality …
Electrochemical detection of miRNA using commercial and hand‐made screen‐printed electrodes: liquid biopsy for cancer management as case of study
The growth of liquid biopsy, ie, the possibility of obtaining health information by analysing
circulating species (nucleic acids, cells, proteins, and vesicles) in peripheric biofluids, is …
circulating species (nucleic acids, cells, proteins, and vesicles) in peripheric biofluids, is …
Circulating MicroRNAs Do Not Provide a Diagnostic Benefit Over Tissue Biopsy in Patients With Brain Metastases
M Ruckova, D Al Tukmachi, M Vecera, T Deissova… - 2023 - researchsquare.com
Background: Brain metastases (BMs) are frequent and devastating complications of
systemic malignancies, necessitating accurate diagnosis and origin identification for …
systemic malignancies, necessitating accurate diagnosis and origin identification for …